Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Intuitive Surgical stock

ISRG
US46120E6023
888024

Price

0
Today +/-
-0
Today %
-0 %

Intuitive Surgical stock price

%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the Intuitive Surgical stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Intuitive Surgical stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Intuitive Surgical stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Intuitive Surgical's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Intuitive Surgical Stock Price History

DateIntuitive Surgical Price
1/27/20250 undefined
1/24/2025584.05 undefined
1/23/2025608.66 undefined
1/22/2025610.45 undefined
1/21/2025604.12 undefined
1/17/2025592.64 undefined
1/16/2025584.08 undefined
1/15/2025580.11 undefined
1/14/2025538.88 undefined
1/13/2025539.75 undefined
1/10/2025547.47 undefined
1/8/2025544.02 undefined
1/7/2025531.88 undefined
1/6/2025542.37 undefined
1/3/2025535.30 undefined
1/2/2025524.03 undefined
12/31/2024521.96 undefined
12/30/2024526.96 undefined

Intuitive Surgical Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Intuitive Surgical, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Intuitive Surgical from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Intuitive Surgical’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Intuitive Surgical. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Intuitive Surgical’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Intuitive Surgical’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Intuitive Surgical’s growth potential.

Intuitive Surgical Revenue, EBIT and net profit per share

DateIntuitive Surgical RevenueIntuitive Surgical EBITIntuitive Surgical Net Income
2030e17.46 B undefined0 undefined6.15 B undefined
2029e15.49 B undefined6.61 B undefined5.3 B undefined
2028e14.2 B undefined5.71 B undefined4.51 B undefined
2027e12.52 B undefined4.8 B undefined3.85 B undefined
2026e11.25 B undefined4.13 B undefined3.35 B undefined
2025e9.72 B undefined3.46 B undefined2.86 B undefined
20248.35 B undefined2.35 B undefined2.32 B undefined
20237.12 B undefined1.78 B undefined1.8 B undefined
20226.22 B undefined1.6 B undefined1.32 B undefined
20215.71 B undefined1.83 B undefined1.7 B undefined
20204.36 B undefined1.07 B undefined1.06 B undefined
20194.48 B undefined1.38 B undefined1.38 B undefined
20183.72 B undefined1.24 B undefined1.13 B undefined
20173.14 B undefined1.08 B undefined670.9 M undefined
20162.71 B undefined961.8 M undefined738.3 M undefined
20152.38 B undefined753.2 M undefined588.8 M undefined
20142.13 B undefined627.2 M undefined418.8 M undefined
20132.27 B undefined852.5 M undefined671 M undefined
20122.18 B undefined878.1 M undefined656.6 M undefined
20111.76 B undefined694.8 M undefined495.1 M undefined
20101.41 B undefined555.2 M undefined381.8 M undefined
20091.05 B undefined377.4 M undefined232.6 M undefined
2008874.9 M undefined310.8 M undefined204.3 M undefined
2007600.83 M undefined206.74 M undefined144.54 M undefined
2006372.7 M undefined107.4 M undefined72 M undefined
2005227.34 M undefined68.77 M undefined94.13 M undefined

Intuitive Surgical Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)NET INCOME (B)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
19971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e2028e2029e2030e
000.010.030.050.070.090.140.230.370.60.871.051.411.762.182.272.132.382.713.143.724.484.365.716.227.128.359.7211.2512.5214.215.4917.46
---160.0096.1541.1826.3951.6564.4963.8861.2945.6720.3734.3224.3523.963.99-5.9211.8713.5115.9618.6720.25-2.6831.028.9714.5017.2416.3615.7611.2613.459.0612.75
--56,340.0030.7741.1845.8348.3563.7767.4066.4069.0070.9471.3972.8972.4572.0870.3866.3166.1569.9270.1769.9269.4565.6569.3267.4466.3867.4657.9750.0845.0139.6736.3832.26
0000.010.020.030.040.090.150.250.410.620.751.031.271.571.591.411.581.892.22.63.112.863.964.24.735.63000000
-0.02-0.03-0.02-0.02-0.02-0.02-0.010.020.090.070.140.20.230.380.50.660.670.420.590.740.671.131.381.061.71.321.82.322.863.353.854.515.36.15
-26.09-37.93--11.1112.50-50.00-355.56308.70-23.40100.0041.6713.7364.2229.9232.532.29-37.7040.6725.51-9.2168.2122.36-23.1360.75-22.4236.0129.1423.0817.1815.0817.0017.4516.07
9.4516.2921.77107.08161.17164.06212.64314.8337.4342.8351.2359.5352.9362.7361.8369.9360.9339.3341.1353.7348.9356.4358.5360.9365.8362357.4362000000
----------------------------------
Details

Keystats

Revenue and Growth

The Intuitive Surgical Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Intuitive Surgical is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (M)INVENTORIES (B)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (B)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (B)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (B)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (B)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (B)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (B)TOTAL CAPITAL (B)
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                                     
0.020.030.090.070.050.110.130.130.240.430.450.560.911.031.321.41.231.562.551.963.063.225.254.344.255.378.83
000.010.010.020.030.040.050.090.130.170.210.250.30.370.30.320.390.430.510.680.650.650.780.941.131.23
000000000000000000000000000
000.010.010.010.010.010.020.020.030.060.060.090.110.120.180.180.170.180.240.410.60.60.590.891.221.49
00.581.713.132.323.393.2411.4515.7319.3418.9528.731.827.176.647.982.673.583.399.2178.8200.2126.3133.9164.3171.70
0.020.030.10.090.080.150.180.210.370.610.70.851.281.471.891.931.812.23.252.814.334.666.635.846.257.8911.55
0000.010.010.010.030.050.060.070.120.130.160.20.240.310.390.430.460.610.811.351.641.952.463.624.65
00000000.070.090.210.450.620.71.141.61.351.261.792.281.891.772.621.764.422.622.120
000000000000000000000000000
004.093.312.578.096.225.355.8123.4756.2256.266.171103.494.174.149.731.5195.866.7112.177.470.549.839.10
00000143.11143.33124.64118.24110.74110.74110.7116.9116.9138.1137.4198201.1201.1201.1240.6307.2336.7343.6348.5348.7347.5
00000000.040.020.020.040.050.070.070.090.130.220.240.260.070.620.680.730.931.241.432.2
000.010.010.010.160.180.290.30.430.770.961.111.62.172.022.152.713.242.973.515.074.547.716.727.557.2
0.030.030.110.10.090.310.350.50.671.041.471.812.393.064.063.953.964.916.495.787.859.7311.1713.5612.9715.4418.74
                                                     
026363618333436373839000000001001001001004004004000
0.080.10.190.190.190.420.430.470.540.690.871.021.321.742.242.522.93.434.214.685.175.766.457.167.78.580
-0.06-0.08-0.09-0.11-0.13-0.14-0.11-0.020.050.190.40.510.720.91.330.980.490.91.570.121.522.493.264.763.54.740
-0-0-0-000-0-000-000-00.010-0-0.01-0-0-0-0.010.02-0.02-0.16-0.0316.53
0000000000001.31.100-0.2-4.2-8.6-11.3-9.820.44.7-7.9-6.619.40
0.020.020.090.080.060.280.320.440.590.891.271.542.042.653.583.53.384.325.784.786.688.269.7311.911.0413.3116.53
000.010.010.010.0100.010.010.030.020.030.040.050.060.050.060.050.070.080.10.120.080.120.150.191.69
12.445.645.678.415.3717.9224.7233.0248.1666.0375.392.4112.1152.5129.5215.6202.3247336.5386.5529.8486.1597.3781.7912.50
12.945.055.76.9111.3515.3725.3136.5653.8277.9899.9145.8162.7191.5205.2224237281243.8333.4376.9397.5431.3493.4557.5522.9
000000000000000000000000000
11.622.021.631.511.030.6100000000000000000000
0.010.010.020.020.030.030.040.060.080.130.160.20.270.320.40.380.50.490.60.660.821.030.971.151.421.662.21
22.521.860.771.840.7000000000000000000000
000000000000000000000000000
00000.21.70.911.011.4219.5543.3469.679.296.977.56878.895.9112.6333.6338.6418.3444.6453.7439.3385.50
22.521.860.772.042.40.911.011.4219.5543.3469.679.296.977.56878.895.9112.6333.6338.6418.3444.6453.7439.3385.50
0.010.010.020.020.030.040.040.060.080.150.210.270.350.420.480.450.580.590.7111.161.451.411.61.862.042.21
0.030.030.110.10.090.310.350.50.671.041.471.812.393.064.063.953.964.916.495.787.849.7111.1413.512.915.3518.74
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Intuitive Surgical provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Intuitive Surgical's financial health and stability.

Assets

Intuitive Surgical's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Intuitive Surgical must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Intuitive Surgical after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Intuitive Surgical's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (B)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (B)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
-0.02-0.03-0.02-0.02-0.02-0.02-0.010.020.090.070.140.20.230.380.50.660.670.420.590.740.671.131.381.071.731.341.82
01123310761013253440465767748992110133216293332392454
00000000-4093-20-15-217-20-38-354186031-857-62-185-280
6-401-60-90-9-282-93817-19-65-2214-92-372-383-321-273-368-619-777
000000000.020.040.040.080.20.250.290.340.370.360.380.420.440.520.670.740.911.071.19
000000000000000000000000000
0000000013116112912415222619417611013814717915834180444447
-0.01-0.03-0.02-0.01-0.02-0.01-0.010.030.070.10.210.280.390.550.680.810.880.670.811.091.141.171.61.482.091.491.81
-2-10-6-5-5-5-22-31-18-24-106-53-96-82-141-104-105-81-53-190-187-425-341-353-532-1,064
-0.020-0.01-0.050.020.01-0.07-0.05-0.1-0.11-0.24-0.3-0.3-0.49-0.48-0.850.26-0.15-0.85-1.280.38-1.05-1.15-0.94-2.461.37-0.36
-0.020-0.01-0.040.020.01-0.07-0.03-0.07-0.1-0.21-0.2-0.25-0.4-0.4-0.70.36-0.05-0.77-1.230.57-0.86-0.73-0.6-2.111.90.7
000000000000000000000000000
1200-10-1-10000000000000000000
4721198222841332195644-91-57-7125-948-716177538-1,8582363174276-2,373-120
48232082038212324211898-667-12119-910-692159514-1,913126-168-8543-2,572-287
000000000236253256558943824-18-24-54-110-171-260-233-198-167
000000000000000000000000000
0.02-0.01-0.010.02-0-00-0.0100.030.090.070.030.060.190.090.23-0.180.110.32-0.390.250.270.46-0.330.291.17
-17.7-32.8-16.8-19.4-24-19.9-137.939.881.7181.7172.2338.8449.8594.7672.4775.4559.5725.21,033.1953.2982.21,172.61,143.31,735.9958.4749.6
000000000000000000000000000

Intuitive Surgical stock margins

The Intuitive Surgical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Intuitive Surgical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Intuitive Surgical.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Intuitive Surgical's sales revenue. A higher gross margin percentage indicates that the Intuitive Surgical retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Intuitive Surgical's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Intuitive Surgical's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Intuitive Surgical's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Intuitive Surgical. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Intuitive Surgical's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Intuitive Surgical Margin History

Intuitive Surgical Gross marginIntuitive Surgical Profit marginIntuitive Surgical EBIT marginIntuitive Surgical Profit margin
2030e67.46 %0 %35.2 %
2029e67.46 %42.69 %34.2 %
2028e67.46 %40.18 %31.76 %
2027e67.46 %38.32 %30.8 %
2026e67.46 %36.71 %29.77 %
2025e67.46 %35.62 %29.42 %
202467.46 %28.12 %27.81 %
202366.39 %24.99 %25.24 %
202267.44 %25.67 %21.25 %
202169.32 %32.09 %29.85 %
202065.65 %24.45 %24.33 %
201969.45 %30.71 %30.8 %
201869.92 %33.42 %30.29 %
201770.17 %34.43 %21.38 %
201669.94 %35.54 %27.28 %
201566.18 %31.59 %24.69 %
201466.32 %29.42 %19.65 %
201370.38 %37.64 %29.62 %
201272.07 %40.3 %30.14 %
201172.49 %39.54 %28.17 %
201072.89 %39.29 %27.02 %
200971.38 %35.87 %22.11 %
200870.96 %35.52 %23.35 %
200768.95 %34.41 %24.06 %
200666.49 %28.82 %19.32 %
200567.55 %30.25 %41.41 %

Intuitive Surgical Stock Sales Revenue, EBIT, Earnings per Share

The Intuitive Surgical earnings per share therefore indicates how much revenue Intuitive Surgical has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Intuitive Surgical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Intuitive Surgical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Intuitive Surgical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Intuitive Surgical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Intuitive Surgical Revenue, EBIT and net profit per share

DateIntuitive Surgical Sales per ShareIntuitive Surgical EBIT per shareIntuitive Surgical Earnings per Share
2030e49.03 undefined0 undefined17.26 undefined
2029e43.48 undefined0 undefined14.87 undefined
2028e39.87 undefined0 undefined12.66 undefined
2027e35.14 undefined0 undefined10.82 undefined
2026e31.59 undefined0 undefined9.4 undefined
2025e27.28 undefined0 undefined8.03 undefined
202423.07 undefined6.49 undefined6.42 undefined
202319.93 undefined4.98 undefined5.03 undefined
202217.19 undefined4.41 undefined3.65 undefined
202115.61 undefined5.01 undefined4.66 undefined
202012.08 undefined2.95 undefined2.94 undefined
201912.49 undefined3.84 undefined3.85 undefined
201810.45 undefined3.49 undefined3.16 undefined
20178.99 undefined3.1 undefined1.92 undefined
20167.65 undefined2.72 undefined2.09 undefined
20156.99 undefined2.21 undefined1.73 undefined
20146.28 undefined1.85 undefined1.23 undefined
20136.28 undefined2.36 undefined1.86 undefined
20125.89 undefined2.37 undefined1.78 undefined
20114.86 undefined1.92 undefined1.37 undefined
20103.9 undefined1.53 undefined1.05 undefined
20092.98 undefined1.07 undefined0.66 undefined
20082.43 undefined0.86 undefined0.57 undefined
20071.71 undefined0.59 undefined0.41 undefined
20061.09 undefined0.31 undefined0.21 undefined
20050.67 undefined0.2 undefined0.28 undefined

Intuitive Surgical business model

Intuitive Surgical Inc is an American company that specializes in the manufacturing of medical robots. The company was founded by Friedman and Green in 1995 and is headquartered in Sunnyvale, California. Starting with the goal of improving and making laparoscopic surgery more efficient, the company has since expanded its offerings and distributes its robots in many countries worldwide. Intuitive Surgical's business model is based on surgeons purchasing the robots and, in some cases, operating them. The cost of a robot can be very high, but this is balanced out by the efficiency achieved through the use of the robots. One of the main advantages of Intuitive Surgical is the fact that the robots have higher precision than traditional surgery. There is less blood loss, less scarring, and therefore a shorter recovery time for the patient. The company has two main products, the Da Vinci System for laparoscopic surgery and the Ion Robotic System for endoscopy. The Da Vinci robot was Intuitive Surgical's first product and was introduced to the market in 2000. The Da Vinci robots are used for a variety of surgeries and provide better visualization and precision for the surgeon. The robot is operated through a console at which the surgeon sits and connects to the robot's instruments. The Ion robot, on the other hand, was recently introduced and is meant for endoscopy. The system offers more precise imaging and the ability to better position the endoscope. The robot also has the capability to extract and analyze biological samples and tissues from the patient. Intuitive Surgical also offers a variety of accessories, such as instruments, consoles, docking stations, and software. The instruments vary depending on the application, ranging from scissors and needle holders to graspers and clippers. The docking stations allow for automatic switching of instruments without the surgeon having to manually change them. The software is used to facilitate the control of the robots and instruments and support data processing. Since its founding in the 1990s, Intuitive Surgical has experienced impressive growth. In 2000, the company had only 14 employees and introduced the Da Vinci robot. Today, the company employs over 5,000 people and sells its products in more than 60 countries worldwide. The company has become a market leader in laparoscopic surgery and has won a variety of awards and accolades. The company is also highly committed to research and development. There is a team of engineers, scientists, and surgeons constantly working to improve the robots and instruments and develop new applications. Intuitive Surgical also has partnerships with leading healthcare companies in the industry to promote collaboration and knowledge exchange. Overall, Intuitive Surgical has had a significant impact on medical care and laparoscopic surgery. The company's robots have already helped many patients receive better medical care and recover faster. Collaboration with other industry experts and ministries also helps optimize the use of the technology and improve patient access to this technology. Intuitive Surgical is one of the most popular companies on Eulerpool.com.

Intuitive Surgical SWOT Analysis

Strengths

Intuitive Surgical Inc benefits from being a market leader in the development and manufacturing of robotic surgical systems. Its flagship product, the da Vinci Surgical System, has set the standard for advanced minimally invasive surgery, providing superior precision and control to surgeons.

The company offers a diverse range of robotic surgical systems and related instruments, enabling it to cater to various medical specialties. This comprehensive product portfolio enhances Intuitive Surgical's competitive advantage and allows it to address the needs of different surgeons and hospitals effectively.

Intuitive Surgical has built a loyal and expanding customer base, comprising hospitals, surgical centers, and healthcare professionals worldwide. The company's innovative technology and proven track record have instilled trust and confidence in its customers, leading to continued strong demand for its products.

Weaknesses

The da Vinci Surgical System and its associated instruments come with a significant price tag, making them expensive investments for hospitals and healthcare institutions. Additionally, the ongoing maintenance costs can pose financial challenges for customers, potentially limiting the company's market penetration in cost-sensitive regions or facilities.

While Intuitive Surgical's technology is widely used across various surgical fields, the majority of its revenue still relies heavily on specific procedures such as prostatectomy and hysterectomy. This concentration exposes the company to risks associated with changes in medical practices, reimbursement policies, or competing technologies.

Opportunities

Intuitive Surgical can explore untapped opportunities in emerging markets, where robotic-assisted surgery adoption is still in its early stages. By expanding its presence and offering flexible pricing options tailored to the local market dynamics, the company can capitalize on the growing demand for advanced surgical technologies.

The field of robotic surgery is rapidly evolving, presenting Intuitive Surgical with opportunities to further enhance its product offerings and maintain its technological leadership. By investing in research and development, the company can introduce innovative features, improve surgical outcomes, and expand into new surgical applications.

Threats

Intuitive Surgical faces intense competition from both established medical device companies and emerging players in the robotic surgical market. Competitors may develop comparable or superior technologies, potentially eroding the market share and pricing power of Intuitive Surgical's products.

The regulatory environment and reimbursement policies surrounding robotic surgery can pose challenges for Intuitive Surgical. Changes in regulations, reimbursement rates, or insurance coverage may impact the adoption and financial viability of its products, affecting the company's revenue and competitive position.

Intuitive Surgical Revenue by Segment

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Intuitive Surgical Revenue by Segment

Segmente202320222021202020192018
Product5.96 B USD-4.79 B USD3.63 B USD3.75 B USD3.09 B USD
Service1.17 B USD-916.2 M USD723.8 M USD724.2 M USD635.1 M USD
  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Intuitive Surgical Revenue by Segment

Segmente202320222021202020192018
Instruments and accessories4.28 B USD-3.1 B USD2.46 B USD2.41 B USD-
Systems1.68 B USD-1.69 B USD1.18 B USD1.35 B USD-
Product-5.2 B USD----
Services--916.2 M USD723.8 M USD724.2 M USD-
Service-1.02 B USD----
  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Intuitive Surgical Revenue by Segment

Segmente202320222021202020192018
Instruments and accessories-----1.96 B USD
Systems-----1.13 B USD
Services-----635.1 M USD
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Intuitive Surgical Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Intuitive Surgical historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Intuitive Surgical shares outstanding

The number of shares was Intuitive Surgical in 2024 — This indicates how many shares 362 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Intuitive Surgical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Intuitive Surgical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Intuitive Surgical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Intuitive Surgical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Intuitive Surgical stock splits

In Intuitive Surgical's history, there have been no stock splits.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Intuitive Surgical.

Intuitive Surgical latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
12/31/20241.79 2.21  (23.13 %)2024 Q4
9/30/20241.67 1.84  (10.37 %)2024 Q3
6/30/20241.57 1.78  (13.38 %)2024 Q2
3/31/20241.44 1.5  (4.44 %)2024 Q1
12/31/20231.51 1.6  (5.71 %)2023 Q4
9/30/20231.44 1.46  (1.35 %)2023 Q3
6/30/20231.35 1.42  (4.99 %)2023 Q2
3/31/20231.22 1.23  (0.47 %)2023 Q1
12/31/20221.28 1.23  (-3.59 %)2022 Q4
9/30/20221.14 1.19  (4.23 %)2022 Q3
1
2
3
4
5
...
10

Eulerpool ESG Scorecard© for the Intuitive Surgical stock

Eulerpool World ESG Rating (EESG©)

75/ 100

🌱 Environment

72

👫 Social

66

🏛️ Governance

86

Environment

Scope 1 - Direct Emissions
7,045
Scope 2 - Indirect emissions from purchased energy
21,338
Scope 3 - Indirect emissions within the value chain
463,262
Total CO₂ emissions
28,383
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees37.2
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Intuitive Surgical shareholders

%
Name
Stocks
Change
Date
8.82951 % The Vanguard Group, Inc.31,448,960730,0466/30/2024
5.06713 % BlackRock Institutional Trust Company, N.A.18,048,099144,2166/30/2024
4.30520 % T. Rowe Price Associates, Inc.15,334,264-704,1786/30/2024
4.16636 % State Street Global Advisors (US)14,839,758-292,6576/30/2024
2.75073 % Fidelity Management & Research Company LLC9,797,5571,000,4536/30/2024
2.06903 % Geode Capital Management, L.L.C.7,369,485218,4516/30/2024
2.06372 % Capital World Investors7,350,54566,2766/30/2024
1.93532 % Invesco Capital Management (QQQ Trust)6,893,21645,3419/30/2024
1.90896 % AllianceBernstein L.P.6,799,342195,6106/30/2024
1.67951 % JP Morgan Asset Management5,982,0861,799,4916/30/2024
1
2
3
4
5
...
10

Intuitive Surgical Executives and Management Board

Dr. Gary Guthart

(57)
Intuitive Surgical Chief Executive Officer, Director (since 2002)
Compensation 10.35 M

Mr. David Rosa

(55)
Intuitive Surgical President
Compensation 6.19 M

Mr. Bob DeSantis

(57)
Intuitive Surgical Executive Vice President and Chief Product Officer
Compensation 5.99 M

Dr. Myriam Curet

(66)
Intuitive Surgical Executive Vice President, Chief Medical Officer
Compensation 4.48 M

Mr. Marshall Mohr

(67)
Intuitive Surgical Executive Vice President - Global Business Services
Compensation 4.44 M
1
2
3
4

Intuitive Surgical Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
SupplierCustomer0,510,390,800,900,720,43
SupplierCustomer0,280,810,790,74
SupplierCustomer0,22-0,04-0,63-0,76-0,75
Surgical Science Sweden AB (publ) Stock
Surgical Science Sweden AB (publ)
SupplierCustomer0,16
Shanghai Fosun Pharm H Stock
Shanghai Fosun Pharm H
SupplierCustomer0,070,340,230,320,390,50
SupplierCustomer0,050,570,670,550,480,67
SupplierCustomer-0,160,380,470,330,240,46
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Stock
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
SupplierCustomer-0,320,29-0,050,670,58
SupplierCustomer-0,410,860,840,890,780,89
1

Most common questions regarding Intuitive Surgical

What values and corporate philosophy does Intuitive Surgical represent?

Intuitive Surgical Inc represents values and a corporate philosophy centered around innovation, patient care, and technological advancements in the field of robotic-assisted surgery. As a leading company in the medical industry, Intuitive Surgical Inc is committed to improving surgical outcomes, enabling minimally invasive procedures, and enhancing the overall patient experience. With their flagship product, the da Vinci Surgical System, Intuitive Surgical Inc has revolutionized the way complex surgeries are performed. By combining their cutting-edge technology and a dedication to continuous improvement, Intuitive Surgical Inc strives to provide healthcare professionals with tools that optimize surgical precision, efficiency, and ultimately, patient outcomes.

In which countries and regions is Intuitive Surgical primarily present?

Intuitive Surgical Inc primarily operates in various countries and regions worldwide. The company has a strong presence in the United States, where it is headquartered. Additionally, Intuitive Surgical Inc has established a significant market presence in Europe, particularly in countries like Germany, France, and the United Kingdom. The company also operates in other parts of the world, including Australia, Japan, China, and South Korea. With its innovative robotic surgical systems and instruments, Intuitive Surgical Inc continues to expand its global footprint, delivering advanced healthcare solutions to patients and healthcare professionals across different regions.

What significant milestones has the company Intuitive Surgical achieved?

Intuitive Surgical Inc has achieved several significant milestones. One notable achievement was the development of the da Vinci Surgical System, a groundbreaking robotic surgical platform that enables surgeons to perform minimally invasive procedures with enhanced precision. The company also introduced the da Vinci Xi System, which offers expanded capabilities and versatility. Moreover, Intuitive Surgical Inc has expanded its global presence by installing over 5,500 da Vinci Systems worldwide. These milestones have solidified Intuitive Surgical Inc's position as a leader in robotic-assisted surgery, providing advanced technology that improves patient outcomes and revolutionizes the healthcare industry.

What is the history and background of the company Intuitive Surgical?

Intuitive Surgical Inc is a renowned American company specializing in robotic-assisted surgical systems. Founded in 1995, the company has a rich history of innovation and is widely recognized for its flagship product, the da Vinci Surgical System. This advanced technology revolutionized minimally invasive surgery by providing surgeons with enhanced precision and control. Intuitive Surgical Inc has continuously improved its robotic systems over the years, expanding its applications to various surgical specialties. The company's commitment to research, development, and training has positioned it as a global leader in robotic surgery, benefiting both patients and healthcare professionals worldwide.

Who are the main competitors of Intuitive Surgical in the market?

Intuitive Surgical Inc faces competition from companies such as TransEnterix Inc, Medtronic Plc, and Johnson & Johnson in the market.

In which industries is Intuitive Surgical primarily active?

Intuitive Surgical Inc is primarily active in the medical device and healthcare industries.

What is the business model of Intuitive Surgical?

The business model of Intuitive Surgical Inc. revolves around the development, manufacturing, and marketing of robotic-assisted surgical systems. Intuitive Surgical's flagship product, the da Vinci Surgical System, enables surgeons to perform minimally invasive surgery with enhanced precision, control, and visualization. By combining robotics, software, and surgical expertise, Intuitive Surgical aims to provide innovative solutions that improve patient outcomes, reduce surgical complexity, and enhance the capabilities of healthcare professionals. Intuitive Surgical Inc. continually invests in research and development to expand its product portfolio and remains committed to supporting surgeons and hospitals worldwide in delivering advanced surgical care.

What is the P/E ratio of Intuitive Surgical 2025?

The P/E ratio cannot be calculated for Intuitive Surgical at the moment.

What is the P/S ratio of Intuitive Surgical 2025?

The P/S cannot be calculated for Intuitive Surgical currently.

What is the Quality Investing of Intuitive Surgical?

The Quality Investing for Intuitive Surgical is 8/10.

What is the revenue of Intuitive Surgical 2025?

The expected Intuitive Surgical revenue is 9.72 B USD.

How high is the profit of Intuitive Surgical 2025?

The expected Intuitive Surgical profit is 2.86 B USD.

What is the business model of Intuitive Surgical

Intuitive Surgical Inc. is a leading company specializing in medical technology, focused on the development and manufacture of robotic systems for surgical procedures. The company is headquartered in Sunnyvale, California and was founded in 1995.

What is the Intuitive Surgical dividend?

Intuitive Surgical pays a dividend of 0 USD distributed over payouts per year.

How often does Intuitive Surgical pay dividends?

The dividend cannot currently be calculated for Intuitive Surgical or the company does not pay out a dividend.

What is the Intuitive Surgical ISIN?

The ISIN of Intuitive Surgical is US46120E6023.

What is the Intuitive Surgical WKN?

The WKN of Intuitive Surgical is 888024.

What is the Intuitive Surgical ticker?

The ticker of Intuitive Surgical is ISRG.

How much dividend does Intuitive Surgical pay?

Over the past 12 months, Intuitive Surgical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Intuitive Surgical is expected to pay a dividend of 0 USD.

What is the dividend yield of Intuitive Surgical?

The current dividend yield of Intuitive Surgical is .

When does Intuitive Surgical pay dividends?

Intuitive Surgical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Intuitive Surgical?

Intuitive Surgical paid dividends every year for the past 0 years.

What is the dividend of Intuitive Surgical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Intuitive Surgical located?

Intuitive Surgical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Intuitive Surgical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Intuitive Surgical from 1/27/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/27/2025.

When did Intuitive Surgical pay the last dividend?

The last dividend was paid out on 1/27/2025.

What was the dividend of Intuitive Surgical in the year 2024?

In the year 2024, Intuitive Surgical distributed 0 USD as dividends.

In which currency does Intuitive Surgical pay out the dividend?

The dividends of Intuitive Surgical are distributed in USD.

All fundamentals about Intuitive Surgical

Our stock analysis for Intuitive Surgical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Intuitive Surgical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.